Lorazepam for Nausea Treatment
Role of Lorazepam in Nausea Management
- Lorazepam is considered a useful adjunct to antiemetic drugs but is not recommended as a single-agent antiemetic for nausea treatment, according to the American Society of Clinical Oncology 1
- The American Society of Clinical Oncology mentions lorazepam as an appropriate option for breakthrough nausea and vomiting when patients have failed first-line therapies 2
- For patients experiencing nausea or vomiting despite optimal prophylaxis, lorazepam may be offered as an additional medication to the standard antiemetic regimen, as suggested by the American Society of Clinical Oncology 2, 3
Appropriate Clinical Scenarios for Lorazepam Use
- Breakthrough nausea: When patients experience nausea despite receiving optimal prophylactic antiemetics, lorazepam may be used, according to the American Society of Clinical Oncology 2
- Anticipatory nausea and vomiting: Lorazepam (1 mg orally at bedtime the night before chemotherapy and 1 mg the morning of chemotherapy) may be beneficial for anticipatory nausea and vomiting, which is often anxiety-related, as noted by the Mayo Clinic 4
First-Line Alternatives for Nausea Management
- 5-HT3 receptor antagonists (ondansetron, granisetron, palonosetron) are the most effective non-sedating first-line antiemetics with high-quality evidence supporting their use, although this fact is from Praxis Medical Insights, a similar recommendation is made by the American Society of Clinical Oncology 6
- For low-emetic-risk situations, a single dose of a 5-HT3 receptor antagonist or dexamethasone (8 mg) is recommended before treatment, according to the American Society of Clinical Oncology 1
- For moderate to high-emetic-risk situations, combination therapy with 5-HT3 antagonists, dexamethasone, and possibly NK1 receptor antagonists is recommended, as suggested by the American Society of Clinical Oncology 7, 2
Practical Recommendations for Lorazepam Use
- Typical dosing: 0.5-2.0 mg either every 4 or 6 hours as needed, according to the National Comprehensive Cancer Network 5
- Available routes: oral, intravenous, or sublingual, as noted by the National Comprehensive Cancer Network 5
- When using lorazepam for breakthrough nausea, clinicians should first re-evaluate the patient's emetic risk, disease status, and concurrent medications to ensure optimal management, according to the American Society of Clinical Oncology 2